Immuneering CorporationIMRXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank33
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-45.34M
↓ 30% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-34.76M
Historical baseline
PeriodValueYoY Change
TTM$-45.34M+17.6%
2024$-55.00M-12.3%
2023$-48.97M-11.0%
2022$-44.10M-42.9%
2021$-30.85M-111.0%
2020$-14.62M-229.1%
2019$-4.44M-